In this multi-center retrospective study, we developed a simple score composed of six variables (age, ascites, albumin, PT, TBIL, and sodium) to predict the 1-year and 3-year survival of TIPS treatment for patients with viral hepatitis cirrhosis-related portal hypertension. The gene discussed is ALB; the disease is portal hypertension.